| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Department of Pediatrics (S.R., C.S.) and Research Unit for Molecular Medicine (N.G.), Skejby University Hospital, Aarhus DK-8200, Denmark; Department of Endocrinology (M.O., I.Y.), Gulhane School of Medicine, 06019 Ankara, Turkey; Department of Medicine (E.B.P.), Holstebro Hospital, DK-7500 Holstebro, Denmark; and Department of Medicine (G.L.R.), Northwestern University Medical School, Chicago, Illinois 60611-3008
Address all correspondence and requests for reprints to: Dr. Søren Rittig, M.D., Department of Pediatrics, Skejby University Hospital, DK-8200 Aarhus N, Denmark. E-mail: . rittig{at}iekf.au.dk
Abstract
The autosomal dominant form of familial neurohypophyseal diabetes insipidus (adFNDI) has been linked to 40 different mutations of the gene encoding the vasopressin-neurophysin II (AVP-NPII) precursor. All of these mutations have been located in either the signal peptide or neurophysin II moiety. We now report a three-generation Turkish kindred in which severe adFNDI cosegregates with a novel missense mutation in the part of the AVP-NPII gene encoding the AVP moiety. This mutation (T
C at position 285 in the genomic sequence) was found in only one allele and predicts a substitution of histidine for tyrosine at position 2 in AVP. Like other adFNDI mutations, this substitution is expected to impair folding and processing of the precursor, in this case by interfering with normal binding of the AVP and NPII moieties. It is associated clinically with inability to concentrate urine during fluid deprivation, a greater than 80% deficiency of AVP secretion, and absence of the posterior pituitary bright spot on magnetic resonance imaging. These findings are consistent with the hypothesis that mutations in the AVP-NPII gene cause adFNDI by directing the production of a folding incompetent precursor that prevents the expression of the normal allele via a cytotoxic effect on the magnocellular neurons.
This article has been cited by other articles:
![]() |
J. H. Robben, N. V. A. M. Knoers, and P. M. T. Deen Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol, August 1, 2006; 291(2): F257 - F270. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ye, X. Li, Y. Chen, H. Sun, W. Wang, T. Su, L. Jiang, B. Cui, and G. Ning Autosomal Dominant Neurohypophyseal Diabetes Insipidus with Linkage to Chromosome 20p13 but without Mutations in the AVP-NPII Gene J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4388 - 4393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Christensen, C. Siggaard, T. J. Corydon, G. L. Robertson, N. Gregersen, L. Bolund, and S. Rittig Differential Cellular Handling of Defective Arginine Vasopressin (AVP) Prohormones in Cells Expressing Mutations of the AVP Gene Associated with Autosomal Dominant and Recessive Familial Neurohypophyseal Diabetes Insipidus J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4521 - 4531. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Friberg, M. Spiess, and J. Rutishauser Degradation of Wild-type Vasopressin Precursor and Pathogenic Mutants by the Proteasome J. Biol. Chem., May 7, 2004; 279(19): 19441 - 19447. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Wahlstrom, M. J. Fowler, W. E. Nicholson, and W. J. Kovacs A Novel Mutation in the Preprovasopressin Gene Identified in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1963 - 1968. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |